359 related articles for article (PubMed ID: 19248043)
1. Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management.
Phan J; Swanson DA; Levy LB; Kudchadker RJ; Bruno TL; Frank SJ
Cancer; 2009 May; 115(9):1827-39. PubMed ID: 19248043
[TBL] [Abstract][Full Text] [Related]
2. Rectal complications after prostate brachytherapy.
Shah SA; Cima RR; Benoit E; Breen EL; Bleday R
Dis Colon Rectum; 2004 Sep; 47(9):1487-92. PubMed ID: 15486745
[TBL] [Abstract][Full Text] [Related]
3. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding.
Akimoto T; Katoh H; Kitamoto Y; Tamaki T; Harada K; Shirai K; Nakano T
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):364-70. PubMed ID: 16690428
[TBL] [Abstract][Full Text] [Related]
4. Rectourethral fistula and massive rectal bleeding from iodine-125 prostate brachytherapy: a case report.
Cherr GS; Hall C; Pineau BC; Waters GS
Am Surg; 2001 Feb; 67(2):131-4. PubMed ID: 11243535
[TBL] [Abstract][Full Text] [Related]
5. Colorectal complications of external beam radiation versus brachytherapy for prostate cancer.
Lesperance RN; Kjorstadt RJ; Halligan JB; Steele SR
Am J Surg; 2008 May; 195(5):616-20; discussion 620. PubMed ID: 18374892
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors and management of rectal bleeding side effects following prostate cancer brachytherapy.
Price JG; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):842-7. PubMed ID: 23845840
[TBL] [Abstract][Full Text] [Related]
7. Incidence and clinical course of hemorrhagic radiation proctitis after iodine-125 prostate brachytherapy.
Mishra MV; Shirazi R; Barrett WL
Clin Genitourin Cancer; 2007 Sep; 5(6):397-400. PubMed ID: 17956713
[TBL] [Abstract][Full Text] [Related]
8. Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding.
Akimoto T; Muramatsu H; Takahashi M; Saito J; Kitamoto Y; Harashima K; Miyazawa Y; Yamada M; Ito K; Kurokawa K; Yamanaka H; Nakano T; Mitsuhashi N; Niibe H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1033-9. PubMed ID: 15519772
[TBL] [Abstract][Full Text] [Related]
9. Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer.
Sherertz T; Wallner K; Merrick G; Ford E; Sutlief S; Cavanagh W; Butler W; True L
Brachytherapy; 2004; 3(3):130-5. PubMed ID: 15533804
[TBL] [Abstract][Full Text] [Related]
10. Rectal function following permanent prostate brachytherapy.
Merrick GS; Butler WM
W V Med J; 2004; 100(1):18-20. PubMed ID: 15119492
[TBL] [Abstract][Full Text] [Related]
11. Novel parameter predicting grade 2 rectal bleeding after iodine-125 prostate brachytherapy combined with external beam radiation therapy.
Shiraishi Y; Hanada T; Ohashi T; Yorozu A; Toya K; Saito S; Shigematsu N
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):182-7. PubMed ID: 23747214
[TBL] [Abstract][Full Text] [Related]
12. Rectourethral fistula after combination radiotherapy for prostate cancer.
Marguet C; Raj GV; Brashears JH; Anscher MS; Ludwig K; Mouraviev V; Robertson CN; Polascik TJ
Urology; 2007 May; 69(5):898-901. PubMed ID: 17482930
[TBL] [Abstract][Full Text] [Related]
13. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
[TBL] [Abstract][Full Text] [Related]
14. Late rectal toxicity after low-dose-rate brachytherapy: incidence, predictors, and management of side effects.
Kishan AU; Kupelian PA
Brachytherapy; 2015; 14(2):148-59. PubMed ID: 25516492
[TBL] [Abstract][Full Text] [Related]
15. Recto-urethral fistula following brachytherapy for localized prostate cancer.
Shakespeare D; Mitchell DM; Carey BM; Finan P; Henry AM; Ash D; Bottomley DM; Al-Qaisieh B
Colorectal Dis; 2007 May; 9(4):328-31. PubMed ID: 17432984
[TBL] [Abstract][Full Text] [Related]
16. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer.
Ishikawa H; Tsuji H; Kamada T; Hirasawa N; Yanagi T; Mizoe JE; Akakura K; Suzuki H; Shimazaki J; Tsujii H
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1084-91. PubMed ID: 16979840
[TBL] [Abstract][Full Text] [Related]
18. [Rectal bleeding after radiotherapy for prostate cancer].
van Roermund JG; de Ridder RJ; Lutgens LC
Ned Tijdschr Geneeskd; 2014; 158():A7698. PubMed ID: 25052354
[TBL] [Abstract][Full Text] [Related]
19. Hyperbaric oxygen therapy for radiation induced proctopathy in men treated for prostate cancer.
Dall'Era MA; Hampson NB; Hsi RA; Madsen B; Corman JM
J Urol; 2006 Jul; 176(1):87-90. PubMed ID: 16753375
[TBL] [Abstract][Full Text] [Related]
20. Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer.
Chrouser KL; Leibovich BC; Sweat SD; Larson DW; Davis BJ; Tran NV; Zincke H; Blute ML
J Urol; 2005 Jun; 173(6):1953-7. PubMed ID: 15879789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
